citalopram has been researched along with Impairment, Light Touch Sensation in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "After three and six weeks of treatment, citalopram significantly improved abdominal pain, bloating, impact of symptoms on daily life, and overall well being compared with placebo." | 9.12 | A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. ( Broekaert, D; Fischler, B; Gevers, AM; Janssens, J; Tack, J; Van Oudenhove, L, 2006) |
| "After three and six weeks of treatment, citalopram significantly improved abdominal pain, bloating, impact of symptoms on daily life, and overall well being compared with placebo." | 5.12 | A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. ( Broekaert, D; Fischler, B; Gevers, AM; Janssens, J; Tack, J; Van Oudenhove, L, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feth, N | 1 |
| Cattapan-Ludewig, K | 1 |
| Jaquenoud Sirot, E | 1 |
| Tack, J | 1 |
| Broekaert, D | 1 |
| Fischler, B | 1 |
| Van Oudenhove, L | 1 |
| Gevers, AM | 1 |
| Janssens, J | 1 |
| Castle, M | 1 |
| Libby, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, Randomized, Placebo-Controlled Multicenter Study to Assess the Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome[NCT00583128] | Phase 2 | 117 participants (Actual) | Interventional | 2007-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for citalopram and Impairment, Light Touch Sensation
| Article | Year |
|---|---|
A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.
Topics: Abdominal Pain; Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Cross-Ov | 2006 |
2 other studies available for citalopram and Impairment, Light Touch Sensation
| Article | Year |
|---|---|
Electric sensations: neglected symptom of escitalopram discontinuation.
Topics: Citalopram; Confusion; Depressive Disorder; Electric Stimulation; Female; Humans; Paresthesia; Photi | 2006 |
Further evidence supporting a psychological component to irritable bowel syndrome.
Topics: Antidepressive Agents, Second-Generation; Anxiety; Citalopram; Humans; Irritable Bowel Syndrome; Som | 2007 |